MAP1LC3A and hepatocellular carcinoma: The LC3 immunohistochemistry of lung metastasis and primary HCC tumors confirmed that LC3 expression significantly increased in metastasis (IOD of lung metastases and primary HCC tumors were 364701±33647 and 19431±1434, P<0.001) (Figure 2B,D).